Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for ANIK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 13.38M
March 31, 2026 13.36M
December 31, 2025 13.89M
September 30, 2025 14.42M
June 30, 2025 14.42M
March 31, 2025 14.34M
December 31, 2024 14.42M
September 30, 2024 14.69M
June 30, 2024 14.84M
March 31, 2024 14.82M
December 31, 2023 14.66M
September 30, 2023 14.64M
June 30, 2023 14.66M
March 31, 2023 14.74M
December 31, 2022 14.62M
September 30, 2022 14.61M
June 30, 2022 14.60M
March 31, 2022 14.52M
December 31, 2021 14.44M
September 30, 2021 14.44M
June 30, 2021 14.42M
March 31, 2021 14.37M
December 31, 2020 14.33M
September 30, 2020 14.21M
June 30, 2020 14.20M
Date Value
March 31, 2020 14.20M
December 31, 2019 14.31M
September 30, 2019 14.27M
June 30, 2019 13.78M
March 31, 2019 14.21M
December 31, 2018 14.21M
September 30, 2018 14.21M
June 30, 2018 14.58M
March 31, 2018 14.74M
December 31, 2017 14.69M
September 30, 2017 14.66M
June 30, 2017 14.66M
March 31, 2017 14.66M
December 31, 2016 14.63M
September 30, 2016 14.62M
June 30, 2016 14.78M
March 31, 2016 14.77M
December 31, 2015 15.04M
September 30, 2015 15.01M
June 30, 2015 15.00M
March 31, 2015 15.00M
December 31, 2014 14.85M
September 30, 2014 14.80M
June 30, 2014 14.80M
March 31, 2014 14.62M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Perspective Therapeutics, Inc. 114.09M
MiMedx Group, Inc. 145.72M
ABVC BioPharma, Inc. 25.77M
Enovis Corp. 57.67M
Edwards Lifesciences Corp. 576.60M